Steven Cohen’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Steven Cohen’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-62,500	Closed	-$28.1K	–	2591
2024 Q1	$28.1K	Hold	62,500	–	–	﹤0.01%	2091
2023 Q4	$46.3K	Hold	62,500	–	–	﹤0.01%	2010
2023 Q3	$54.4K	Hold	62,500	–	–	﹤0.01%	2107
2023 Q2	$117K	Hold	62,500	–	–	﹤0.01%	1513
2023 Q1	$231K	Hold	62,500	–	–	﹤0.01%	1436
2022 Q4	$238K	Hold	62,500	–	–	﹤0.01%	1243
2022 Q3	$494K	Hold	62,500	–	–	﹤0.01%	1171
2022 Q2	$1.31M	Hold	62,500	–	–	0.01%	1021
2022 Q1	$2.35M	Hold	62,500	–	–	0.01%	851
2021 Q4	$3.51M	Hold	62,500	–	–	0.01%	744
2021 Q3	$4.51M	Hold	62,500	–	–	0.02%	681
2021 Q2	$5.99M	Buy	+62,500	New	+$6.9M	0.03%	577

Other funds holding NBSE

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Steven Cohen's NBSE Position: Q2 2024 in Review

Steven Cohen sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2024, closing a stake of 62,500 shares — an estimated $28.1K sold.

Steven Cohen first reported a position in NBSE in Q2 2021 and held it in 12 quarters. The position peaked at $5.99M in Q2 2021. 3 funds tracked by Wall St. Rank hold NBSE as of Q2 2024.

Steven Cohen reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Steven Cohen sold 62,500 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $28.1K.
Steven Cohen first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
Steven Cohen's NeuBase Therapeutics, Inc. Common Stock position peaked at $5.99M in Q2 2021.
3 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.